Related Experiment Videos

Lovastatin reduces apoptosis and downregulates the CD40 expression induced by TNF-alpha in cerebral vascular

Rong Lin1, Juntian Liu, Ning Peng

  • 1Department of Pharmacology, Xi'an Jiaotong University School of Medicine, Xi'an, Shaanxi, P.R. China. linrong@mail.xjtu.edu.cn

Current Neurovascular Research
|February 14, 2006
PubMed

Insights

Lovastatin demonstrates neuroprotection in cerebrovascular diseases by reducing inflammation. This statin inhibits the CD40-CD40 ligand pathway, decreasing nitric oxide and apoptosis in vascular cells.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Inflammation is a key risk factor in neurological diseases.
  • Statins show potential neuroprotective effects.
  • The CD40-CD40 ligand system mediates chronic inflammation.

Purpose of the Study:

  • To investigate if lovastatin offers neuroprotection by inhibiting CD40 expression.
  • To examine lovastatin's effects on CD40, apoptosis, nitric oxide (NO), and nitric oxide synthase (NOS) in cerebral vascular endothelial cells (CVECs).

Main Methods:

  • CVECs were preincubated with varying concentrations of lovastatin.
  • Cells were exposed to tumor necrosis factor alpha (TNF-alpha).
  • Measurements included cellular viability, NO levels, NOS activity, apoptosis, and CD40 expression.

Main Results:

  • Lovastatin protected CVECs from TNF-alpha-induced viability loss.
  • Lovastatin dose-dependently inhibited TNF-alpha-induced increases in NO, NOS activity, apoptosis, and CD40 expression.
  • Anti-CD40 antibody also reduced TNF-alpha-induced apoptosis.

Conclusions:

  • The CD40-CD40 ligand pathway has a pro-inflammatory role in CVECs.
  • Lovastatin exhibits anti-inflammatory effects in cerebrovascular diseases, independent of its lipid-lowering properties.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.